APA (7th ed.) Citation

Hou, W., Hong, W., Cai, S., Guo, D., Yan, Z., Zhu, J., . . . Tang, B. (2025). RRM2‐targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling. iMeta, 4(5), 1. https://doi.org/10.1002/imt2.70067

Chicago Style (17th ed.) Citation

Hou, Weiliang, et al. "RRM2‐targeted Nanocarrier Enhances Radiofrequency Ablation Efficacy in Hepatocellular Carcinoma Through Ferroptosis Amplification and Immune Remodeling." IMeta 4, no. 5 (2025): 1. https://doi.org/10.1002/imt2.70067.

MLA (9th ed.) Citation

Hou, Weiliang, et al. "RRM2‐targeted Nanocarrier Enhances Radiofrequency Ablation Efficacy in Hepatocellular Carcinoma Through Ferroptosis Amplification and Immune Remodeling." IMeta, vol. 4, no. 5, 2025, p. 1, https://doi.org/10.1002/imt2.70067.